Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Gustoeson Aug 01, 2017 9:35am

92 Views

Post# 26532659

RE:RE:Reverse split for uplist

skier59 wrote: I don't think it will be required Gustoes. Firstly our O/S share count is very low. Secondly we are on a Major Exchange in the USA which enables the Funds to start picking up positions, and these guys usually look to acquire big chunks. The Big Cash is in the USA, not Canada, so we need to get more on board in the USA. This will naturally occur and shares will be pulled out of Canada. Short Term Traders in Canada are about to have their pants-shorts stolen from them very soon. I'm confident our SP will naturally grow so that an uplisting on the TSX main board will come soon enough. Right now I think there are too many shares controlled in Canada and this will change, especially now that we are regarded as a company with clinical results, not just pre-clinical as we were just a few months ago.

Gustoes wrote: Does anyone think a reverse split would be justified at this point? I do.
Based on current early data, I'd say this company is a lock for the upward trajectory that many of us have be projecting pre-trial.... enough to justify the administrative expense and not have to worry about sp slipping outside min requirements in an uplist.
TLT needs to get off the venture.

Good points.
So you think the OCTQX opens things up a bit. Looking at their top 50 now... wish I still held my Nemaska @.11cents a few years back.
Thanks for the insight.

Bullboard Posts

HPQ Silicon updates shareholders on Fumed Silica Reactor developments